Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jul 8;10(7):1733.
doi: 10.3390/cells10071733.

Extracellular Vesicles in Multiple Sclerosis: Role in the Pathogenesis and Potential Usefulness as Biomarkers and Therapeutic Tools

Marianna D'Anca  1 , Chiara Fenoglio  2 , Francesca Romana Buccellato  3 , Caterina Visconte  1 , Daniela Galimberti  1   3 , Elio Scarpini  1   3
Affiliations
Review

Extracellular Vesicles in Multiple Sclerosis: Role in the Pathogenesis and Potential Usefulness as Biomarkers and Therapeutic Tools

Marianna D'Anca et al. Cells. .

Abstract

Although extracellular vesicles (EVs) were initially relegated to a waste disposal role, nowadays, they have gained multiple fundamental functions working as messengers in intercellular communication as well as exerting active roles in physiological and pathological processes. Accumulating evidence proves the involvement of EVs in many diseases, including those of the central nervous system (CNS), such as multiple sclerosis (MS). Indeed, these membrane-bound particles, produced in any type of cell, carry and release a vast range of bioactive molecules (nucleic acids, proteins, and lipids), conferring genotypic and phenotypic changes to the recipient cell. This means that not only EVs per se but their content, especially, could reveal new candidate disease biomarkers and/or therapeutic agents. This review is intended to provide an overview regarding current knowledge about EVs' involvement in MS, analyzing the potential versatility of EVs as a new therapeutic tool and source of biomarkers.

Keywords: biomarkers; extracellular vesicles; extracellular vesicles cargo; microRNAs; multiple sclerosis; therapeutic approach.

PubMed Disclaimer

References

    1. Wolf P. The nature and significance of platelet products in human plasma. Br. J. Haematol. 1967 doi: 10.1111/j.1365-2141.1967.tb08741.x. - DOI - PubMed
    1. Van der Pol E., Böing A.N., Harrison P., Sturk A., Nieuwland R. Classification, functions, and clinical relevance of extracellular vesicles. Pharmacol. Rev. 2012;64:676–705. doi: 10.1124/pr.112.005983. - DOI - PubMed
    1. Kalra H., Drummen G.P.C., Mathivanan S. Focus on extracellular vesicles: Introducing the next small big thing. Int. J. Mol. Sci. 2016;17 doi: 10.3390/ijms17020170. - DOI - PMC - PubMed
    1. Maas S.L.N., Breakefield X.O., Weaver A.M. Extracellular Vesicles: Unique Intercellular Delivery Vehicles. Trends Cell Biol. 2017;27:172–188. doi: 10.1016/j.tcb.2016.11.003. - DOI - PMC - PubMed
    1. Yáñez-Mó M., Siljander P.R.M., Andreu Z., Zavec A.B., Borràs F.E., Buzas E.I., Buzas K., Casal E., Cappello F., Carvalho J., et al. Biological properties of extracellular vesicles and their physiological functions. J. Extracell. Vesicles. 2015;4:1–60. doi: 10.3402/jev.v4.27066. - DOI - PMC - PubMed

Publication types

MeSH terms